Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

NCT00004794 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
Acquired Immunodeficiency Syndrome

Interventions

DRUG: cidofovir

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]